Particle.news
Download on the App Store
4 ARTICLES
·
5h ago

Centrus Soars on U.S. Uranium Push as Expansion Awaits Funding

The rally reflects Washington's nuclear fuel push, with Centrus' expansion still contingent on DOE funding and firm utility contracts.

Image
Image

Overview

  • Shares rose 53.7% in September after the Trump administration moved to bolster domestic nuclear materials and recommended expanding a strategic uranium reserve.
  • A 2024 ban on Russian uranium, with waivers expiring by 2028, leaves the U.S. replacing roughly 25% of enriched uranium previously sourced from Russia.
  • Centrus is currently the only NRC-licensed commercial HALEU producer in the U.S. and is delivering under a DOE contract after shipping 900 kilograms in June.
  • Phase III of that contract calls for another 900 kilograms of HALEU by June 30, 2026, while a planned Piketon build-out depends on DOE support, private capital and long-term utility commitments.
  • The company reports raising over $1.2 billion and securing about $2 billion in contingent utility purchase commitments as the stock jumps 323% year to date, with some coverage flagging valuation risk after its market cap topped $5.5 billion.